Wecome Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Wecome Pharmaceutical Co Ltd cash flow-to-debt ratio. Wecome Pharmaceutical Co Ltd (300878) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥-1.42 Million could theoretically repay 0% of its total liabilities (CN¥458.37 Million) in one year. Check cash flow quality index of Wecome Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Wecome Pharmaceutical Co Ltd (2013–2024)
Cash flow-to-debt ratio of Wecome Pharmaceutical Co Ltd from 2013 to 2024. Historical debt coverage capacity for Wecome Pharmaceutical Co Ltd across 12 annual periods. Check how aggressively does Wecome Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Wecome Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2013–2024)
Wecome Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2013 to 2024. Year-by-year debt coverage analysis for Wecome Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Wecome Pharmaceutical Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.06x | CN¥-27.17 Million | CN¥478.50 Million | ▼ -162.3% |
| 2023 | 0.09x | CN¥58.29 Million | CN¥639.23 Million | ▼ -68.8% |
| 2022 | 0.29x | CN¥146.57 Million | CN¥502.25 Million | ▲ +222.5% |
| 2021 | -0.24x | CN¥-67.74 Million | CN¥284.28 Million | ▼ -236.0% |
| 2020 | 0.18x | CN¥42.81 Million | CN¥244.39 Million | ▼ -44.7% |
| 2019 | 0.32x | CN¥112.76 Million | CN¥356.02 Million | ▼ -25.8% |
| 2018 | 0.43x | CN¥105.57 Million | CN¥247.29 Million | ▲ +155.6% |
| 2017 | 0.17x | CN¥29.00 Million | CN¥173.68 Million | ▼ -82.6% |
| 2016 | 0.96x | CN¥100.15 Million | CN¥104.25 Million | ▲ +197.8% |
| 2015 | 0.32x | CN¥29.63 Million | CN¥91.84 Million | ▼ -33.5% |
| 2014 | 0.49x | CN¥46.01 Million | CN¥94.82 Million | ▲ +35.9% |
| 2013 | 0.36x | CN¥25.98 Million | CN¥72.78 Million | — |